Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data.
about
Liver transplantation: Current status and challengesDonation after cardio-circulatory death liver transplantationLiver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipientsPrediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysisKidney and liver transplants from donors after cardiac death: initial experience at the London Health Sciences Centre.Donations After Circulatory Death in Liver Transplant.Developing a donation after cardiac death risk index for adult and pediatric liver transplantationUtilization of expanded criteria donors in liver transplantation.A metabolic index of ischemic injury for perfusion-recovery of cadaveric rat liversLiver transplantation for hepatitis C from donation after cardiac death donors: an analysis of OPTN/UNOS data.A fitness index for transplantation of machine-perfused cadaveric rat livers.Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center.Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.Development of organ-specific donor risk indices.The Impact of Ischemia/Reperfusion Injury on Liver Allografts from Deceased after Cardiac Death versus Deceased after Brain Death Donors.Donation after cardiac death: a 29-year experience.Mass Spectrometry Based Metabolomics Comparison of Liver Grafts from Donors after Circulatory Death (DCD) and Donors after Brain Death (DBD) Used in Human Orthotopic Liver Transplantation.Prevention of hepatitis C recurrence after liver transplantation: An update.How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?Expanded criteria donors.Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort studyMesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation.The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story.Challenges in machine perfusion preservation for liver grafts from donation after circulatory death.Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature.Donation after cardiac death in abdominal organ transplantation.Increasing the donor pool: consideration of prehospital cardiac arrest in controlled donation after circulatory death for liver transplantation.Perioperative complications in liver transplantation using donation after cardiac death grafts: a propensity-matched study.Attitudes and barriers to the use of DCD livers: Comparison of a U.S. transplant center survey to the United Network for Organ Sharing data.The influence of functional warm ischemia time on DCD liver transplant recipients' outcomes.Current challenges and future directions for liver transplantation.Recent advances in understanding and managing liver transplantationDCD liver transplant infection: experience from a single centre in China.Introduction of a Framework for Dynamic Knowledge Representation of the Control Structure of Transplant Immunology: Employing the Power of Abstraction with a Solid Organ Transplant Agent-Based Model.Biliary complications after liver transplantation.Elderly donor liver grafts are not associated with a higher incidence of biliary complications after liver transplantation: results of a national multicenter study.Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers.Donation after cardiac death organs for patients with hepatitis C virus: are we rolling the dice, or are they just as good as any?Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
P2860
Q26749457-BA001269-A472-47F6-8922-D227308B04ACQ28728002-D0D4895A-5647-4E55-92CB-EDD46E3877FAQ30275773-AEB0DE5C-B209-4728-AB82-5C065B2D943CQ30277088-3EACD439-45E9-4568-B0D8-B6D2224E9047Q33721402-028D75EE-37EE-47E1-A6A5-B9A619A95761Q33754902-D2DE5D6C-D7C4-4625-8ED5-A69AE9787308Q33771943-3F651EE9-59EA-47AF-A0CC-5C958557280CQ33842801-795433AB-32F3-4B79-AB7A-06392AA3F558Q33871968-70E4E063-E154-42DA-8E9D-F55BEB1A6999Q34110081-61ABD80B-F599-4A0D-9883-154C289C6B1CQ34120704-75C9B52C-234D-4D7E-952C-41DD952E1AF8Q34316604-C6C6FA53-DACF-4B52-93E9-A86072FE55F0Q35010160-4F0C78B6-0138-42D4-BB43-08FA54C52C89Q35010230-F93442D7-0817-40A3-8821-E917D21DFD5FQ35903771-5C672B49-3606-4EB7-A9A8-6ED72C8088E8Q35919682-4A7799D5-87A4-4BDE-9636-C7E970F22B58Q35975893-F85F1FAA-8933-42C2-B603-0A2F2AD1DECEQ36189744-70E78A46-9C79-4ED1-AF42-5EC1DB4354A8Q36220172-BEDBD7E6-AAFF-40ED-8AF5-AFFB5383D015Q36492605-17F0B8BC-91D9-4942-A41F-D5B3A0D15A6BQ36733650-43A9FA82-FCBA-45B2-9044-FDF3AE6BB763Q37172631-808FA69B-1A56-40A9-AA07-9EE55173CF5EQ37374724-EAF0EDAC-E6A3-4EE1-9DC7-3D92391B5866Q37466276-DC0BA3C4-B3FD-4B34-A4AE-A9629A95C992Q37497136-87036860-1099-48D5-A0C1-C0E220AE6DBBQ37613628-ED5DEE97-8DB8-437D-A539-25931D22755CQ38017159-210ADDBB-2667-45E2-A46B-39DC158C35E3Q38154246-ABD66956-6F8D-49D1-AA23-44DCF2D04885Q38202916-6E2FC1EF-CB7D-42E6-A9AB-623F505393F9Q38611740-490030CF-B3F5-4D0D-BADF-0E44C321BC2CQ38643796-76D7BBBB-CD22-49BB-8AE2-7439DD008340Q38820685-419D4E89-A531-4B75-8FE8-C2C95E0EDE54Q39095917-2C302F69-8E6C-447C-81CF-4E92D721D380Q39752203-B72A6FAC-18C4-4BD1-AA4A-B9349C78D5B3Q40289666-AD2B133A-7476-4E80-9FAD-DC427450ECDEQ41694479-5B9A32C1-4E53-496F-B5A9-F6F5537974BAQ41724644-1238C2CB-4D33-4661-B7FC-95BA34710A1CQ42595101-C2BDC0F1-AA8B-4993-BBA1-09931BA46337Q43036082-83B039EF-4771-4673-B115-95A938DB5C3AQ43037184-604C9477-AF70-4B45-9067-FBF1BC2C4596
P2860
Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Risk factors for graft surviva ...... an analysis of OPTN/UNOS data.
@ast
Risk factors for graft surviva ...... an analysis of OPTN/UNOS data.
@en
type
label
Risk factors for graft surviva ...... an analysis of OPTN/UNOS data.
@ast
Risk factors for graft surviva ...... an analysis of OPTN/UNOS data.
@en
prefLabel
Risk factors for graft surviva ...... an analysis of OPTN/UNOS data.
@ast
Risk factors for graft surviva ...... an analysis of OPTN/UNOS data.
@en
P2093
P2860
P1476
Risk factors for graft surviva ...... an analysis of OPTN/UNOS data.
@en
P2093
P2860
P304
P356
10.1111/J.1600-6143.2006.01243.X
P407
P577
2006-04-01T00:00:00Z